M Bourliere

25.4k citations
323 papers · 9.5k · 2 hit papers · h-index 50

Impact in

  • Hepatology top 0.05%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Hepatitis Viruses Studies and Epidemiology
  • Epidemiology top 0.1%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 195
    • Hepatocellular Carcinoma Treatment and Prognosis 25
    • Liver Disease and Transplantation 24
    • Liver Disease Diagnosis and Treatment 124
    • Hepatitis B Virus Studies 98

M Bourliere

306 papers receiving 9.1k citations

M Bourliere's Hit Papers

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin 2014 · 424 citations
4240+5+11Years since publication250500750

Peers

M Bourliere
Comparison fields: 5 of 119
  • Hepatology 6.8k
  • Epidemiology 5.4k
  • Infectious Diseases 1.0k
  • Transplantation 74
  • Hematology 302
Replace Paul J. Pockros with:
Paul J. Pockros United States
Lennox J. Jeffers United States
John Moore Vierling United States
Massimo G. Colombo Italy
Pietro Andreoné Italy
Stefan Zeuzem Germany
Robert P. Perrillo United States
Eiji Tanaka Japan
Jenny Heathcote Canada
M. Diago Spain
M Bourliere relative to Paul J. Pockros United States Paul J. Pockros's profile →
Citations per field
00.5×1.5×
Paul J. Pockros · 1×
Citations per year

Countries citing papers authored by M Bourliere

Since Specialization
Citations

This map shows the geographic impact of M Bourliere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Bourliere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Bourliere more than expected).

Fields of papers citing papers by M Bourliere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Bourliere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Bourliere. The network helps show where M Bourliere may publish in the future.

Co-authors

The 25 scholars most cited alongside M Bourliere, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Bourliere Line = papers co-authored together M Bourliere links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 323 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Hit paper breakdown →
2009831
2
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003463
3
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
Hit paper breakdown →
2014424
4 2007371
5 2007257
6 2007208
7 2013187
8 1999182
9 2006161
10 2009141
11 2016138
12 2006129
13 2005126
14 2014126
15 2010123
16 2006123
17 1996117
18 2013117
19 2006113
20 2011113

About M Bourliere

M Bourliere is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Genetics, having authored 323 papers that have together received 9.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (195 papers), Liver Disease Diagnosis and Treatment (124 papers), Hepatitis B Virus Studies (98 papers), Hepatocellular Carcinoma Treatment and Prognosis (25 papers), Liver Disease and Transplantation (24 papers), Systemic Lupus Erythematosus Research (21 papers), HIV/AIDS drug development and treatment (21 papers) and Chronic Lymphocytic Leukemia Research (9 papers). The work is most often cited by research in Hepatology (6.8k citations), Epidemiology (5.4k citations), Infectious Diseases (1.0k citations), Transplantation (74 citations) and Hematology (302 citations). M Bourliere has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Philippe Halfon, Stanislas Pol, Guillaume Pénaranda, Denis Ouzan, Christophe Hézode, Victor de Lédinghen, Laurent Castéra, Christophe Renou, Geoffrey M Dusheiko and Jean–Pierre Bronowicki. Their work appears in journals such as Journal of Hepatology, Liver International, Journal of Viral Hepatitis, Hepatology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact